568 related articles for article (PubMed ID: 12447114)
1. Hypocretin/orexin and sleep: implications for the pathophysiology and diagnosis of narcolepsy.
Overeem S; Scammell TE; Lammers GJ
Curr Opin Neurol; 2002 Dec; 15(6):739-45. PubMed ID: 12447114
[TBL] [Abstract][Full Text] [Related]
2. Symptomatic narcolepsy, cataplexy and hypersomnia, and their implications in the hypothalamic hypocretin/orexin system.
Nishino S; Kanbayashi T
Sleep Med Rev; 2005 Aug; 9(4):269-310. PubMed ID: 16006155
[TBL] [Abstract][Full Text] [Related]
3. Hypocretin deficiency in narcolepsy with cataplexy is associated with a normal body core temperature modulation.
Grimaldi D; Agati P; Pierangeli G; Franceschini C; Guaraldi P; Barletta G; Vandi S; Cevoli S; Plazzi G; Montagna P; Cortelli P
Chronobiol Int; 2010 Sep; 27(8):1596-608. PubMed ID: 20854137
[TBL] [Abstract][Full Text] [Related]
4. The narcoleptic borderland: a multimodal diagnostic approach including cerebrospinal fluid levels of hypocretin-1 (orexin A).
Bassetti C; Gugger M; Bischof M; Mathis J; Sturzenegger C; Werth E; Radanov B; Ripley B; Nishino S; Mignot E
Sleep Med; 2003 Jan; 4(1):7-12. PubMed ID: 14592354
[TBL] [Abstract][Full Text] [Related]
5. Progressive dopamine and hypocretin deficiencies in Parkinson's disease: is there an impact on sleep and wakefulness?
Wienecke M; Werth E; Poryazova R; Baumann-Vogel H; Bassetti CL; Weller M; Waldvogel D; Storch A; Baumann CR
J Sleep Res; 2012 Dec; 21(6):710-7. PubMed ID: 22747735
[TBL] [Abstract][Full Text] [Related]
6. Relationship between clinical characteristics of narcolepsy and CSF orexin-A levels.
Nakamura M; Kanbayashi T; Sugiura T; Inoue Y
J Sleep Res; 2011 Mar; 20(1 Pt 1):45-9. PubMed ID: 20642748
[TBL] [Abstract][Full Text] [Related]
7. Narcolepsy: pathophysiology and pharmacology.
Nishino S
J Clin Psychiatry; 2007; 68 Suppl 13():9-15. PubMed ID: 18078360
[TBL] [Abstract][Full Text] [Related]
8. The role of cerebrospinal fluid hypocretin measurement in the diagnosis of narcolepsy and other hypersomnias.
Mignot E; Lammers GJ; Ripley B; Okun M; Nevsimalova S; Overeem S; Vankova J; Black J; Harsh J; Bassetti C; Schrader H; Nishino S
Arch Neurol; 2002 Oct; 59(10):1553-62. PubMed ID: 12374492
[TBL] [Abstract][Full Text] [Related]
9. [Narcolepsy: a new perspective on diagnosis and treatment].
Fronczek R; van der Zande WL; van Dijk JG; Overeem S; Lammers GJ
Ned Tijdschr Geneeskd; 2007 Apr; 151(15):856-61. PubMed ID: 17472116
[TBL] [Abstract][Full Text] [Related]
10. Sleepiness that cannot be overcome: narcolepsy and cataplexy.
Han F
Respirology; 2012 Nov; 17(8):1157-65. PubMed ID: 22471619
[TBL] [Abstract][Full Text] [Related]
11. Rapid eye movement sleep behaviour disorder in patients with narcolepsy is associated with hypocretin-1 deficiency.
Knudsen S; Gammeltoft S; Jennum PJ
Brain; 2010 Feb; 133(Pt 2):568-79. PubMed ID: 20129934
[TBL] [Abstract][Full Text] [Related]
12. Hypocretin (orexin) deficiency predicts severe objective excessive daytime sleepiness in narcolepsy with cataplexy.
Baumann CR; Khatami R; Werth E; Bassetti CL
J Neurol Neurosurg Psychiatry; 2006 Mar; 77(3):402-4. PubMed ID: 16484654
[TBL] [Abstract][Full Text] [Related]
13. The neurobiology of hypocretins (orexins), narcolepsy and related therapeutic interventions.
Zeitzer JM; Nishino S; Mignot E
Trends Pharmacol Sci; 2006 Jul; 27(7):368-74. PubMed ID: 16766052
[TBL] [Abstract][Full Text] [Related]
14. [Narcolepsy with cataplexy].
Dauvilliers Y; Arnulf I
Rev Neurol (Paris); 2008; 164(8-9):634-45. PubMed ID: 18805301
[TBL] [Abstract][Full Text] [Related]
15. Undetectable levels of CSF hypocretin-1 (orexin-A) in two prepubertal boys with narcolepsy.
Tsukamoto H; Ishikawa T; Fujii Y; Fukumizu M; Sugai K; Kanbayashi T
Neuropediatrics; 2002 Feb; 33(1):51-2. PubMed ID: 11930279
[TBL] [Abstract][Full Text] [Related]
16. [Narcolepsy--new implications of molecular biology].
Knudsen S; Jennum PJ
Ugeskr Laeger; 2006 Oct; 168(43):3699-704. PubMed ID: 17069732
[TBL] [Abstract][Full Text] [Related]
17. The role of the hypothalamic neuropeptides hypocretin/orexin in the sleep-wake cycle.
Salin-Pascual RJ
Isr Med Assoc J; 2001 Feb; 3(2):144-6. PubMed ID: 11344826
[TBL] [Abstract][Full Text] [Related]
18. Emerging treatments for narcolepsy and its related disorders.
Nishino S; Okuro M
Expert Opin Emerg Drugs; 2010 Mar; 15(1):139-58. PubMed ID: 20166851
[TBL] [Abstract][Full Text] [Related]
19. Hypocretin/orexin, sleep and narcolepsy.
Hungs M; Mignot E
Bioessays; 2001 May; 23(5):397-408. PubMed ID: 11340621
[TBL] [Abstract][Full Text] [Related]
20. Narcolepsy without cataplexy: 2 subtypes based on CSF hypocretin-1/orexin-A findings.
Oka Y; Inoue Y; Kanbayashi T; Kuroda K; Miyamoto M; Miyamoto T; Ikeda A; Shimizu T; Hishikawa Y; Shibasaki H
Sleep; 2006 Nov; 29(11):1439-43. PubMed ID: 17162990
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
